CapitalBio Technology

Medical Devices & EquipmentSeries ABeijing, Chinacapitalbiotech.com

Latest round

Series A

Last raised

Dec 2017

Total raised

Undisclosed

Investors

6

About CapitalBio Technology

Based in Beijing, China and established in 2012, CapitalBio Technology Inc. focuses on developing and providing health-care solutions and products including broad spectrum of microarray and microfluidic chips and related instruments, software and databases.

Who invested in CapitalBio Technology

6 investors across 2 rounds

See all investors in CapitalBio Technology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Dec 18, 2017

    Amount

    Undisclosed

    Investors

    Locked

  2. Series A

    Jun 7, 2016

    Amount

    Undisclosed

    Investors

    Locked

Questions about CapitalBio Technology

Who invested in CapitalBio Technology?

CapitalBio Technology has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has CapitalBio Technology raised?

CapitalBio Technology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did CapitalBio Technology last raise money?

CapitalBio Technology's most recent round on record is a Series A, in Dec 2017.

What does CapitalBio Technology do?

Based in Beijing, China and established in 2012, CapitalBio Technology Inc.

Where is CapitalBio Technology headquartered?

CapitalBio Technology is headquartered in Beijing, China.

Which VCs invest in companies like CapitalBio Technology?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at CapitalBio Technology's stage. Their profiles are linked below.

Raising like CapitalBio Technology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.